The UK Medicines and Healthcare products Regulatory Agency (MHRA) is issuing a patient alert card for men prescribed finasteride. The card is intended to raise awareness of the drug’s psychiatric side effects and sexual dysfunction, including the possibility that sexual dysfunction may continue after treatment is stopped.
Actualités réglementaires25 août 2026•1 min de lecture
MHRA Introduces Patient Alert Card for Finasteride Users
A new patient alert card warns men on finasteride of psychiatric side effects and persistent sexual dysfunction.
Compilé par l'équipe PharmaCountry · Source : MHRA
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note